Stanford
http://www.stanfordgroup.com/#Stanford provides institutional investment services and private wealth management services. The firm also offers equity research to its clients in the consumer, media, energy, financial, healthcare, technology and water/environment sectors.
View Older Stories View More Recent Stories
-
Syros Pharmaceuticals (SYRS) Releases Foundational Data Supporting Ongoing Phase 2 Clinical Trial of SY-1425 for Genomically Defined AML & MDS Patients
-
Pennymac Financial Services (PFSI) Announces Ted Tozer Is Joining Its Board of Directors
-
Abeona Therapeutics (ABEO) Announces Guidance from FDA to Commence Pivotal Phase 3 for EB-101 Gene Therapy for Patients with Epidermolysis Bullosa
-
Twilio (TWLO) Names Jeff Epstein to Board of Directors
-
UPDATE: Horizon Pharma (HZNP) Presents Study Results for PROCYSBI (Cysteamine Bitartrate) Delayed-Release Capsules
-
iBeat, the Lifesaving Smartwatch, Extends Seed Round to $4.5 Million; Builds Out Executive Bench with Hires from Apple and Stanford
-
Achaogen (AKAO) Names Dr. Karen Bernstein to its Board of Directors
-
Stanford Health Care and Lucile Packard Children's Hospital Stanford re-verified as a Level 1 trauma center
-
Milestone Scientific (MLSS) Names Daniel Goldberger as CEO
-
ITUS Corporation (ITUS) Appoints Amit Kumar as New CEO
-
CHF Solutions (CHFS) Granted FDA IDE Approval for Clinical Study of Aquadex FlexFlow Aquapheresis System for Pediatric Use
-
Stanford Graduate School of Business Names Darius Teter as New Executive Director of Stanford Seed
-
Stanford Graduate School of Business Names Darius Teter as New Executive Director of Stanford Seed
-
ChromaDex (CDXC) Appoints Dr. Rudolph Tanzi, Harvard Neurology Professor to Scientific Advisory Board
-
San Francisco SEO and Social Media Expert, Jason McDonald Announces Summer, 2017, Course at Stanford
-
Torex Announces the Results of Its 2017 Meeting of Shareholders
-
Pennymac Financial Services (PFSI) Approves $50M Buyback Plan
-
OvaScience (OVAS) Names Christopher Kroeger as CEO
-
Cellular Biomedicine Group (CBMG) Names Michael A. Caligiuri MD as Chair of External Advisory Board
-
Autodesk (ADSK) Names Andrew Anagnost President and CEO
-
Audentes Therapeutics (BOLD) Appoints Jennifer Jarrett to Board of Directors
-
Tandem Diabetes (TNDM) Presents Findings from PLGS Feasibility Study and Announces Approval of IDE for Pivotal Trial
-
Syros Pharmaceuticals (SYRS) Names Srinivas Akkaraju to Board
-
Atlas Financial Holdings (AFH) Names Wally Walker to Board
-
Cypress Semiconductor (CY) Executive Chairman Ray Bingham Resigns from Board
-
Harvard Bioscience (HBIO) Names James Green as Chairman
-
Eli Lilly & Co. (LLY) Updates Data for Abemaciclib with Phase 3 MONARCH 2 Data Demonstrating Superior Progression-Free Survival in Advanced Breast Cancer at ASCO Meetings
-
Myriad Genetics (MYGN) Announces Results from 2,000 Patient Study of myRisk Hereditary Cancer Test at ASCO
-
Endologix (ELGX) Announces Positive Clinical Data from Ovation LUCY Study
-
Forward Pharma (FWP) Appeals Initial Decision in U.S. Patent Interference
-
Hanover Insurance Group (THG) Elects Michael Price to Board of Directors
-
Abeona Therapeutics (ABEO) Granted Rare Pediatric Disease Designation for EB-101 Gene Therapy Product for Patients with Epidermolysis Bullosa
-
Stanford GSB Recognizes Student Leaders Committed to Social Change
-
Edison International (EIX) and Southern California Edison Appoint Michael Camunez to Board
-
Juno Therapeutics (JUNO) Appoints Jay Flatley to Board of Directors
-
NCI Building Systems (NCS) Elects James Metcalf to Board of Directors
-
CBRE Group (CBG) Names Beth Cobert to Board of Directors
-
Tanger Factory Outlet Centers (SKT) Appoints Thomas McDonough as COO
-
Sensata Technologies (ST) Appoints Connie Skidmore to Board of Directors
-
Callidus Software, Inc. (CALD) Appoints Andres Botero as CMO; Giles House Promoted to CPO
-
Eiger BioPharmaceuticals (EIGR) Announces Results Demonstrating Benefit of Ubenimex and LTB4 Modulation in Experimental Lymphedema
-
Stonemor Partners (STON) Appoints R. Paul Grady as CEO and Mark Miller as CFO
-
Eiger BioPharmaceuticals (EIGR) Completes Enrollment of Phase 2 LIBERTY Study of Ubenimex in PAH
-
Morningstar (MORN) Elects Caroline Tsay to Board of Directors
-
Form 4 Energy XXI Gulf Coast, For: May 10 Filed by: SPRINGEL STANFORD
-
Form 3 Energy XXI Gulf Coast, For: May 10 Filed by: SPRINGEL STANFORD
-
Dick's Sporting Goods (DKS) COO to Retire
-
The countdown is on for the 2017 opening of the new Lucile Packard Children's Hospital Stanford
-
Stanford Seed Celebrates Five Years of Success, Announces Expansion to India
-
Nevsun Resources (NSU) Appoints Peter Kukielski as CEO

